Literature DB >> 9252154

Differential expression of S-adenosylmethionine synthetase isozymes in different cell types of rat liver.

K Shimizu-Saito1, S Horikawa, N Kojima, J Shiga, H Senoo, K Tsukada.   

Abstract

Mammalian S-adenosylmethionine (AdoMet) synthetase exists as two isozymes, liver-type and nonhepatic-type enzymes, which are the products of two different genes. It is known that the liver-type isozyme is only expressed in adult liver. Whereas, the nonhepatic-type isozyme is widely distributed in various tissues. In addition to the liver-type isozyme, a minor amount of the nonhepatic-type isozyme is also detected in adult liver. To investigate the distribution of these two isozymes in the liver in detail, the localization of these two isozymes was examined in each cell type of liver using a combination of cell fractionation technique and Western blot analysis. In the parenchymal cells, the liver-type isozyme protein was predominantly expressed, and a small amount of the nonhepatic-type isozyme protein was also detected. On the other hand, in the stellate cells the nonhepatic-type isozyme protein was exclusively or only expressed. Interestingly, a large amount of both isozymes were present in endothelial and Kupffer cell fraction. Using both antibodies to anti-rat nonhepatic-type and liver-type isozymes, respectively, immunohistochemical analysis clearly confirmed these results. In addition, in cultured hepatocellular carcinoma cells (FAA-HTC1), the nonhepatic-type isozyme protein only was detected, and the liver-type isozyme protein completely disappeared. This result indicates that the changes in the isozyme expression is regulated within the parenchymal cells. Administration of hepatotoxic drug carbon tetrachloride (CCl4) to rats resulted in about 40% to 50% reduction of enzyme activity in parenchymal cells and stellate cells compared with those of control rats. However, enzyme activity in endothelial and Kupffer cell fraction was not changed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252154     DOI: 10.1002/hep.510260224

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells.

Authors:  Komal Ramani; Maria Lauda Tomasi
Journal:  Hepatology       Date:  2012-04-23       Impact factor: 17.425

2.  Methionine adenosyltransferases in liver health and diseases.

Authors:  Komal Ramani; Shelly C Lu
Journal:  Liver Res       Date:  2017-09

Review 3.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Correlation between the expression of methionine adenosyltransferase and the stages of human colorectal carcinoma.

Authors:  K Ito; S Ikeda; N Kojima; M Miura; K Shimizu-Saito; I Yamaguchi; I Katsuyama; K Sanada; T Iwai; H Senoo; S Horikawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Role of methionine adenosyltransferase α2 and β phosphorylation and stabilization in human hepatic stellate cell trans-differentiation.

Authors:  Komal Ramani; Shant Donoyan; Maria Lauda Tomasi; Sunhee Park
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

6.  Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.

Authors:  Laura Llacuna; Montserrat Marí; Josep M Lluis; Carmen García-Ruiz; José C Fernández-Checa; Albert Morales
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

7.  Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation.

Authors:  Komal Ramani; Heping Yang; John Kuhlenkamp; Lauda Tomasi; Hidekazu Tsukamoto; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

8.  Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.

Authors:  Tagreed A Mazi; Gaurav V Sarode; Anna Czlonkowska; Tomasz Litwin; Kyoungmi Kim; Noreene M Shibata; Valentina Medici
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

9.  Methyl Metabolism and the Clock: An Ancient Story With New Perspectives.

Authors:  Jean-Michel Fustin
Journal:  J Biol Rhythms       Date:  2022-04-05       Impact factor: 3.649

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.